ReviewCurrent urology reports2012
Advanced renal mass imaging: diffusion and perfusion MRI.
Review in Current urology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- DTI for the assessment of disease stage in patients with glomerulonephritis--correlation with renal histology.European radiology · 2015Trial
- Scientific Status Quo of Small Renal Lesions: Diagnostic Assessment and Radiomics.Journal of clinical medicine · 2024Review
- Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma: A Critical Analysis of the Current Literature.Cancers · 2023Review
- Recent advances in imaging techniques of renal masses.World journal of radiology · 2022Review
- Mono, bi- and tri-exponential diffusion MRI modelling for renal solid masses and comparison with histopathological findings.Cancer imaging : the official publication of the International Cancer Imaging Society · 2018Article
- Article
- Magnetic resonance imaging as an adjunct diagnostic tool in computed tomography defined Bosniak IIF-III renal cysts: a multicenter study.World journal of urology · 2018Article
- A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy.European urology · 2015Review
- Diffusion weighted imaging and diffusion tensor imaging in the evaluation of transplanted kidneys.European journal of radiology open · 2015Article
- MRI phenotype in renal cancer: is it clinically relevant?Topics in magnetic resonance imaging : TMRI · 2014Review
- Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer.Biologics : targets & therapy · 2012Article
- Diffusion-weighted magnetic resonance imaging for differentiating between benign and malignant thoracic lymph nodes: a meta-analysis.Radiologia brasileiraArticle
- Diffusion-weighted magnetic resonance imaging in cystic renal masses.Canadian Urological Association journal = Journal de l'Association des urologues du CanadaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computed tomography (CT) is considered the imaging modality of choice in evaluation of renal lesions. The advantages of magnetic resonance imaging (MRI) compared to CT include superior soft tissue contrast, avoidance of ionizing radiation and iodinated contrast media, and the possibility of performing functional and advanced imaging techniques such as diffusion-weighted (DWI) and perfusion-weighted imaging (PWI). Although the traditional role of MRI in the evaluation of renal mass is primarily that of a problem-solving tool, DWI and PWI are expanding the role of MRI in management of renal cell cancers. DWI and PWI have shown considerable promise not only in renal lesion detection and characterization as benign or malignant, but also in assessment of renal cell cancer subtype and nuclear grade. Furthermore, these techniques have the potential to assist with tailoring patient- and disease-specific management by providing surgical planning in patients with localized renal cell cancer and assessing treatment response in patients with advanced renal cell cancer undergoing targeted chemotherapy.
Indexed as
Identifiers
22081252What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.